Obesity as a risk factor for triple-negative breast cancers: a systematic review and meta-analysis

被引:0
|
作者
Mariaelena Pierobon
Cara L. Frankenfeld
机构
[1] George Mason University,Department of Global and Community Health
来源
关键词
Triple-negative breast cancer; Obesity; Systematic review; Meta-analysis;
D O I
暂无
中图分类号
学科分类号
摘要
Triple-negative breast cancer (TNBC) is a subtype of breast tumor with unique characteristics in terms of clinical−pathological presentation, prognosis, and response to therapy. Epidemiological investigations focusing on the identification of risk factors involved in the onset and progression of TNBCs have identified unique demographic, anthropometric, and reproductive characteristics involved in the etiopathogenesis of this subtype of breast tumors. This systematic review and meta-analysis evaluates the association between TNBCs and obesity and menopause status. Eligible articles were identified through three databases and secondary reference analysis. The search was conducted from the first record to February 2012. Eleven original articles meeting a priori established inclusion criteria were incorporated in the quantitative analysis. Case−case and case–control comparisons were performed. In addition, a case–case comparison was conducted before and after stratification according to menopausal status. Based on the level of between-study heterogeneity, pooled odds ratio (OR) and 95 % confidence interval were calculated using fixed or random models. The case−case comparison showed a significant association between TNBC and obesity (OR: 1.20; 95 % CI: 1.03−1.40). These results were confirmed by the case–control comparison (OR: 1.24; 95 % CI: 1.06−1.46). Once stratification based on menopausal status was applied to the case–case analysis, significant results were observed only in the pre-menopausal group (OR: 1.43; 95 % CI: 1.23−1.65). According to this analysis, obese women are at a greater risk of presenting with a TNBC than non-obese women, and menopause status may be a mitigating factor. If validated, these findings should be taken into consideration for the development of targeted preventive programs.
引用
收藏
页码:307 / 314
页数:7
相关论文
共 50 条
  • [31] Circulating adipokines and risk of obesity related cancers: A systematic review and meta-analysis
    Yoon, Yeong Sook
    Kwon, A. Rom
    Lee, Yoon Kyung
    Oh, Sang Woo
    OBESITY RESEARCH & CLINICAL PRACTICE, 2019, 13 (04) : 329 - 339
  • [32] Efficacy of breast conservative surgery versus modified radical mastectomy for triple-negative breast cancer: A systematic review and meta-analysis
    Wu, Hong-xing
    Lin, Zi-wen
    Song, Tian-ye
    Piao, Ying-shi
    ASIAN JOURNAL OF SURGERY, 2022, 45 (07) : 1491 - 1493
  • [33] Prognostic value of tumor-infiltrating lymphocytes in patients with triple-negative breast cancer: a systematic review and meta-analysis
    Gao, Guoxuan
    Wang, Zihan
    Qu, Xiang
    Zhang, Zhongtao
    BMC CANCER, 2020, 20 (01)
  • [34] The value of adjuvant radiotherapy on survival and recurrence in triple-negative breast cancer: A systematic review and meta-analysis of 5507 patients
    O'Rorke, M. A.
    Murray, L. J.
    Brand, J. S.
    Bhoo-Pathy, N.
    CANCER TREATMENT REVIEWS, 2016, 47 : 12 - 21
  • [35] Impact of platinum-based chemotherapy on the prognosis of early triple-negative breast cancer: a systematic review and meta-analysis
    Zhao, Fuxing
    Shen, Guoshuang
    Dong, Qiuxia
    Xin, Yuanfang
    Huo, Xingfa
    Wang, Miaozhou
    Liu, Zhen
    Zhao, Yi
    Ren, Dengfeng
    Xie, Qiqi
    Liu, Zhilin
    Li, Zitao
    Gao, Lihong
    Du, Feng
    Zhao, Jiuda
    CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (06) : 2025 - 2040
  • [36] Addition of immunotherapy to chemotherapy for metastatic triple-negative breast cancer: A systematic review and meta-analysis of randomized clinical trials
    Huo, Xingfa
    Shen, Guoshuang
    Liu, Zhen
    Liang, Yuhua
    Li, Jinming
    Zhao, Fuxing
    Ren, Dengfeng
    Zhao, Jiuda
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 168
  • [37] Impact of platinum-based chemotherapy on the prognosis of early triple-negative breast cancer: a systematic review and meta-analysis
    Fuxing Zhao
    Guoshuang Shen
    Qiuxia Dong
    Yuanfang Xin
    Xingfa Huo
    Miaozhou Wang
    Zhen Liu
    Yi Zhao
    Dengfeng Ren
    Qiqi Xie
    Zhilin Liu
    Zitao Li
    Lihong Gao
    Feng Du
    Jiuda Zhao
    Clinical and Experimental Medicine, 2023, 23 : 2025 - 2040
  • [38] Role of circulating tumor DNA in early-stage triple-negative breast cancer: a systematic review and meta-analysis
    Zhang, Diana
    Jahanfar, Shayesteh
    Rabinowitz, Judy B.
    Dower, Joshua
    Song, Fei
    Wu, Cherng-Horng
    Hu, Xiao
    Tracy, Phillip
    Basik, Mark
    Medford, Arielle
    Lin, Po-Han
    Huang, Chiun-Sheng
    Bidard, Francois-Clement
    Renault, Shufang
    Pai, Lori
    Buss, Mary
    Parsons, Heather A.
    Schlam, Ilana
    BREAST CANCER RESEARCH, 2025, 27 (01)
  • [39] Prognostic value of tumor-infiltrating lymphocytes in patients with triple-negative breast cancer: a systematic review and meta-analysis
    Guoxuan Gao
    Zihan Wang
    Xiang Qu
    Zhongtao Zhang
    BMC Cancer, 20
  • [40] Immune checkpoint inhibitors plus neoadjuvant chemotherapy in early triple-negative breast cancer: a systematic review and meta-analysis
    Yuanfang Xin
    Guoshuang Shen
    Yonghui Zheng
    Yumei Guan
    Xingfa Huo
    Jinming Li
    Dengfeng Ren
    Fuxing Zhao
    Zhen Liu
    Zitao Li
    Jiuda Zhao
    BMC Cancer, 21